| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 61.263 | 65 |
| GSM780708 | Untreated after 4 days (C2_1) | 56.8903 | 62 |
| GSM780709 | Untreated after 4 days (C3_1) | 64.8444 | 67 |
| GSM780719 | Untreated after 4 days (C1_2) | 49.9428 | 48 |
| GSM780720 | Untreated after 4 days (C2_2) | 52.394 | 55 |
| GSM780721 | Untreated after 4 days (C3_2) | 57.5874 | 62 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 58.091 | 63 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 60.5257 | 65 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 51.2783 | 52 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 56.0981 | 61 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 56.1672 | 61 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 55.9998 | 61 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 57.7355 | 63 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 56.1749 | 61 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 50.5735 | 50 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 72.0234 | 70 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 56.7242 | 62 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 55.2895 | 60 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 54.2241 | 58 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 63.0859 | 66 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 50.1448 | 49 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 54.0878 | 58 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 58.7275 | 63 |